Evaluation of Clinical outcomes among non-valvular atrial fibrillatIon patients with renal dysfunction treated with warfarin or reduced dose rivaroxaban (CALLIPER)

First published 28/11/2017

Last updated 02/07/2024

EU PAS number:

EUPAS21253

Study

Finalised

Documents

Study protocol

Initial protocol

OS_Protocol_RenalDysfunction_MarketScan_v5

English (297.71 KB - PDF)View document

Updated protocol

19721_Study Protocol_V2.0_Redacted

First published: 22/02/2024

English (885.39 KB - PDF)View document

Study results

19721_CALLIPER_EU PAS Abstract_2019-07-31_Redacted

English (221.14 KB - PDF)View document

Study report

19721_CALLIPER_Clinical Study Report_2019-07-31_Redacted

English (9.89 MB - PDF)View document

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs